Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Brain MRI Findings and Neuro-Psychiatric Involvement in Paroxysmal Nocturnal Hemoglobinuria (PNH)

Wilma Barcellini, Elisa Scola, Silvia Lanfranconi, Marika Grottaroli, Francesca Binda, Bruno Fattizzo, MD, Anna Zaninoni, Gloria Valcamonica, Carla Boschetti, Massimiliano Buoli, Carlo Alfredo Altamura, Nereo Bresolin, Fabio Triulzi, Alberto Zanella, Agostino Cortelezzi, MD

Blood (2016) 128 (22): 4800.

https://doi.org/10.1182/blood.V128.22.4800.4800

Published: 2016

Journal Articles

Predictors of Outcome and Response to Therapy in Primary Autoimmune Hemolytic Anemia: A Gimema Study of 307 Patients

Blood (2014) 124 (21): 1346.

https://doi.org/10.1182/blood.V124.21.1346.1346

Published: 2014

Journal Articles

Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients

Blood (2014) 124 (19): 2930–2936.

https://doi.org/10.1182/blood-2014-06-583021

Published: 2014

Includes: Supplemental data

Journal Articles

Clinical Heterogeneity Of Autoimmune Hemolytic Anemia: A 35-Years Retrospective Study Of 157 Patients

Wilma Barcellini, MD, Bruno Fattizzo, MD, Tommaso Radice, MD, Anna Zaninoni, BS, Nicoletta Revelli, Maria Antonietta Villa, Carla Boschetti, MD, Agostino Cortelezzi, MD, Alberto Zanella, M.D.

Blood (2013) 122 (21): 3428.

https://doi.org/10.1182/blood.V122.21.3428.3428

Published: 2013

Journal Articles

Genetic Polymorphism of the Complement Receptor-1 ( CR1 ) Gene Correlates with the Clinical Response to Eculizumab of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Tommaso Rondelli, BS, Antonio M. Risitano, MD, PhD, Régis Peffault de Latour, MD, Benedetta Peruzzi, PhD, Ricci Patrizia, BS, Wilma Barcellini, MD, Anna Paola Iori, Carla Boschetti, MD, Veronica Valle, MD, Veronique Frémeaux-Bacchi, PhD, Maria De Angioletti, PhD, Gerard Socie, Lucio Luzzatto, MD, FRCP, FRCPath, Rosario Notaro, MD

Blood (2012) 120 (21): 983.

https://doi.org/10.1182/blood.V120.21.983.983

Published: 2012

Journal Articles

A Case of Congenital Red Cell Pyruvate Kinase Deficiency Associated with Hereditary Spherocytosis

Cristina Vercellati, PhD, Anna Paola Maria Luisa Marcello, PhD, Elisa Fermo, PhD, Paola Bianchi, PhD, Carla Boschetti, Alessandra Iurlo, M.D., Alberto Zanella, M.D., Wilma Barcellini, MD

Blood (2011) 118 (21): 5272.

https://doi.org/10.1182/blood.V118.21.5272.5272

Published: 2011

Journal Articles

Two Atypical Severe Cda Forms Presenting as Hydrops Foetalis Are Caused by Mutations in the SEC23B Gene.

Elisa Fermo, Paola Bianchi, Cristina Vercellati, Wilma Barcellini, Carla Boschetti, Anna Paola Marcello, Alberto Zanella

Blood (2009) 114 (22): 1981.

https://doi.org/10.1182/blood.V114.22.1981.1981

Published: 2009

Journal Articles

An Unusual Case of ‘Delayed‘ Febrile Non Hemolytic Transfusion Reaction in a Thalassemia Major Patient with Asymptomatic Plasmodium Falciparum Infection.

Carla Boschetti, Franca Radaelli, Mariangela Colombi, Cristina Vercellati, Luisa Caspani, Romualdo Grande, Maria Domenica Cappellini, Alberto Zanella

Blood (2009) 114 (22): 4186.

https://doi.org/10.1182/blood.V114.22.4186.4186

Published: 2009

Journal Articles

Identification of SEC23B as the Gene Responsible for Congenital Dyserythropoietic Anemia Type II using a Proteomic-Genomic Approach.

Paola Bianchi, Elisa Fermo, Cristina Vercellati, Carla Boschetti, Wilma Barcellini, Alessandra Iurlo, Anna Paola Marcello, Pier Giorgio Righetti, Alberto Zanella

Blood (2009) 114 (22): 4028.

https://doi.org/10.1182/blood.V114.22.4028.4028

Published: 2009

Journal Articles

Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab

Blood (2009) 113 (17): 4094–4100.

https://doi.org/10.1182/blood-2008-11-189944

Published: 2009

Journal Articles

C3-Mediated Extravascular Hemolysis as Additional Mechanism of Disease in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated by the Complent Inhibitor Eculizumab

Blood (2008) 112 (11): 485.

https://doi.org/10.1182/blood.V112.11.485.485

Published: 2008

Journal Articles

Clinical and Haematologic Features of 300 Patients Affected by Hereditary Spherocytosis as a Function of the Type of the Membrane Protein Defect.

Wilma Barcellini, MD, Mariagabriella Mariani, PhD, Cristina Vercellati, PhD, Anna P. Marcello, PhD, Elisa Fermo, PhD, Paola Pedotti, Carla Boschetti, MD, Alberto Zanella, MD

Blood (2007) 110 (11): 1724.

https://doi.org/10.1182/blood.V110.11.1724.1724

Published: 2007

Journal Articles

Immunological, Molecular and Cytokine Changes after Reduced Intensity Bone Marrow Transplantation for PNH: A 2 Years Follow-Up.

Wilma Barcellini, MD, Francesca G. Imperiali, PhD, Anna Zaninoni, PhD, Elisa Fermo, PhD, Carla Boschetti, MD, Davide Soligo, MD, Giorgio Lambertenghi Deliliers, MD, Alberto Zanella, MD

Blood (2005) 106 (11): 5388.

https://doi.org/10.1182/blood.V106.11.5388.5388

Published: 2005

NARROW

Brain MRI Findings and Neuro-Psychiatric Involvement in Paroxysmal Nocturnal Hemoglobinuria (PNH)

Predictors of Outcome and Response to Therapy in Primary Autoimmune Hemolytic Anemia: A Gimema Study of 307 Patients

Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients

Clinical Heterogeneity Of Autoimmune Hemolytic Anemia: A 35-Years Retrospective Study Of 157 Patients

Genetic Polymorphism of the Complement Receptor-1 ( CR1 ) Gene Correlates with the Clinical Response to Eculizumab of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

A Case of Congenital Red Cell Pyruvate Kinase Deficiency Associated with Hereditary Spherocytosis

Two Atypical Severe Cda Forms Presenting as Hydrops Foetalis Are Caused by Mutations in the SEC23B Gene.

An Unusual Case of ‘Delayed‘ Febrile Non Hemolytic Transfusion Reaction in a Thalassemia Major Patient with Asymptomatic Plasmodium Falciparum Infection.

Identification of SEC23B as the Gene Responsible for Congenital Dyserythropoietic Anemia Type II using a Proteomic-Genomic Approach.

Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab

C3-Mediated Extravascular Hemolysis as Additional Mechanism of Disease in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated by the Complent Inhibitor Eculizumab

Clinical and Haematologic Features of 300 Patients Affected by Hereditary Spherocytosis as a Function of the Type of the Membrane Protein Defect.

Immunological, Molecular and Cytokine Changes after Reduced Intensity Bone Marrow Transplantation for PNH: A 2 Years Follow-Up.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only